Eoin Durkan
Dublin City University
4 Papers
1 Citations
Eoin Durkan is an academic researcher from Dublin City University. The author has contributed to research in topics: Type 2 diabetes & Aerobic exercise. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Serum OPG/TRAIL ratio predicts the presence of cardiovascular disease in people with Type 2 Diabetes Mellitus.
Hannah Forde,Colin Davenport,Keith D. Rochfort,R.G. Wallace,Eoin Durkan,Amar Agha,Christopher J. Thompson,William Tormey,Donal J. O’Gorman,Philip M. Cummins,D. Smith +10 more
TL;DR: In this article , the authors compared serum levels of TRAIL, OPG and OPG/TRAIL ratio in people with Type 2 diabetes mellitus, with and without a history of CVD, and controls, and determined which of these indices, if any, predict cardiovascular risk.
4
An evaluation of the DEXLIFE ‘self-selected’ lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial
Grainne O'Donoghue,Grainne O'Donoghue,Aileen Kennedy,Gregers S. Andersen,Eoin Durkan,Tanja Thybo,Margaret Sinnott,John J. Nolan,Donal J. O’Gorman +8 more
TL;DR: This study aims to assess the clinical and psychological impact of the DEXLIFE ‘self-selected’ lifestyle modification programme in adults at risk of developing type 2 diabetes through a two-group parallel-randomised controlled trial.
Phenotypic Responses to a Lifestyle Intervention Do Not Account for Inter-Individual Variability in Glucose Tolerance for Individuals at High Risk of Type 2 Diabetes.
Grainne O'Donoghue,Aileen Kennedy,Gregers S. Andersen,Bernadette Carr,Stephen Cleary,Eoin Durkan,Heidi Davis,Kristine Færch,Paula Fitzpatrick,Helena Kenny,Noel McCaffrey,Javier Monedero,Enda Murphy,John Noone,Tommi Suvitaival,Tanja Thybo,Michael Wheeler,Dorte Vistisen,John J. Nolan,John J. Nolan,Donal J. O’Gorman +20 more
TL;DR: It is found that phenotypic characteristics from standard clinical and physiological parameters were not sufficient to account for the inter-individual variability in glucose tolerance following a 12 weeks lifestyle intervention in inidivuals at high risk for type 2 diabetes.